Literature DB >> 11825994

Quantification of human immunodeficiency virus type 1 proviral DNA by using TaqMan technology.

Yuqi Zhao1, Min Yu, Johann W Miller, Mingzhong Chen, Eric G Bremer, William Kabat, Ram Yogev.   

Abstract

A protocol for quantification of human immunodeficiency virus type 1 (HIV-1) proviral DNA with the TaqMan technology was developed and validated. The assay was specific for HIV-1, with an analytic sensitivity of 10 copies and a linear dynamic range of >6 logs. Viral RNA levels, when at a stable state, were highly correlated with proviral DNA levels in 80 specimens of 18 HIV-infected children.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11825994      PMCID： PMC153359          DOI： 10.1128/JCM.40.2.675-678.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team.

Authors:  S A Nachman; K Stanley; R Yogev; S Pelton; A Wiznia; S Lee; L Mofenson; S Fiscus; M Rathore; E Jimenez; W Borkowsky; J Pitt; M E Smith; B Wells; K McIntosh
Journal:  JAMA       Date:  2000-01-26       Impact factor: 56.272

3.  PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells.

Authors:  C Christopherson; Y Kidane; B Conway; J Krowka; H Sheppard; S Kwok
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  A quantitative PCR method for the assay of HIV-1 provirus load in peripheral blood mononuclear cells.

Authors:  J M Bennett; S Kaye; N Berry; R S Tedder
Journal:  J Virol Methods       Date:  1999-12       Impact factor: 2.014

5.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team.

Authors:  A Wiznia; K Stanley; P Krogstad; G Johnson; S Lee; J McNamara; J Moye; J B Jackson; H Mendez; R Aguayo; A Dieudonne; A Kovacs; M Bamji; E Abrams; S Rana; J Sever; S Nachman
Journal:  AIDS Res Hum Retroviruses       Date:  2000-08-10       Impact factor: 2.205

7.  Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay.

Authors:  J Izopet; C Tamalet; C Pasquier; K Sandres; B Marchou; P Massip; J Puel
Journal:  J Med Virol       Date:  1998-01       Impact factor: 2.327

8.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.

Authors:  P M Holland; R D Abramson; R Watson; D H Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

9.  HIV-1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long-term infected individuals.

Authors:  S Jurriaans; J T Dekker; A de Ronde
Journal:  AIDS       Date:  1992-07       Impact factor: 4.177

10.  Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.

Authors:  M E Sharkey; I Teo; T Greenough; N Sharova; K Luzuriaga; J L Sullivan; R P Bucy; L G Kostrikis; A Haase; C Veryard; R E Davaro; S H Cheeseman; J S Daly; C Bova; R T Ellison; B Mady; K K Lai; G Moyle; M Nelson; B Gazzard; S Shaunak; M Stevenson
Journal:  Nat Med       Date:  2000-01       Impact factor: 87.241
View more
  11 in total

1.  Quantification of human immunodeficiency virus type 1 proviral DNA by the TaqMan real-time PCR assay.

Authors:  Zhibing Yun; Eva Fredriksson; Anders Sönnerborg
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

2.  Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes.

Authors:  Peilin Li; Theodore Ruel; Katsuya Fujimoto; Hiroyu Hatano; Steven Yukl; Leigh Anne Eller; Teri Liegler; Moses Kamya; Anne Gassasira; Grant Dorsey; Philip J Rosenthal; Diane V Havlir; Joseph K Wong
Journal:  J Virol Methods       Date:  2010-09-21       Impact factor: 2.014

3.  Detection of human immunodeficiency virus type 1 DNA in dried blood spots by a duplex real-time PCR assay.

Authors:  Wei Luo; Hua Yang; Kimberly Rathbun; Chou-Pong Pau; Chin-Yih Ou
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection.

Authors:  Agustín Valenzuela-Fernández; Susana Alvarez; Mónica Gordon-Alonso; Marta Barrero; Angeles Ursa; J Román Cabrero; Gerónimo Fernández; Salvador Naranjo-Suárez; Maria Yáñez-Mo; Juan M Serrador; M Angeles Muñoz-Fernández; Francisco Sánchez-Madrid
Journal:  Mol Biol Cell       Date:  2005-09-07       Impact factor: 4.138

5.  Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

Authors:  Francois Rouet; Didier K Ekouevi; Marie-Laure Chaix; Marianne Burgard; Andre Inwoley; Thomas D'Aquin Tony; Christine Danel; Xavier Anglaret; Valeriane Leroy; Philippe Msellati; Francois Dabis; Christine Rouzioux
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

6.  Different human resting memory CD4+ T cell subsets show similar low inducibility of latent HIV-1 proviruses.

Authors:  Kyungyoon J Kwon; Andrew E Timmons; Srona Sengupta; Francesco R Simonetti; Hao Zhang; Rebecca Hoh; Steven G Deeks; Janet D Siliciano; Robert F Siliciano
Journal:  Sci Transl Med       Date:  2020-01-29       Impact factor: 17.956

7.  Circulating proviral HIV DNA and HIV-associated dementia.

Authors:  Bruce Shiramizu; Suzanne Gartner; Andrew Williams; Cecilia Shikuma; Silvia Ratto-Kim; Michael Watters; Joleen Aguon; Victor Valcour
Journal:  AIDS       Date:  2005-01-03       Impact factor: 4.177

8.  Amount of HIV DNA in peripheral blood mononuclear cells is proportional to the severity of HIV-1-associated neurocognitive disorders.

Authors:  Bruce Shiramizu; Andrew E Williams; Cecilia Shikuma; Victor Valcour
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

9.  Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler real-time PCR.

Authors:  Benoît Kabamba-Mukadi; Philippe Henrivaux; Jean Ruelle; Nicole Delferrière; Monique Bodéus; Patrick Goubau
Journal:  BMC Infect Dis       Date:  2005-03-21       Impact factor: 3.090

Review 10.  Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice.

Authors:  Simone Belmonti; Simona Di Giambenedetto; Francesca Lombardi
Journal:  Diagnostics (Basel)       Date:  2021-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.